Global and Japan Influenza Virus Vaccine (H1N1) Market Insights, Forecast to 2027

Global and Japan Influenza Virus Vaccine (H1N1) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Influenza Virus Vaccine (H1N1) Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Market by Application
1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application
1.3.2 3 To 10 Years Old
1.3.3 10 To 18 Years Old
1.3.4 Above 18 Years Old
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Virus Vaccine (H1N1) Market Size, Estimates and Forecasts
2.1.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027
2.1.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027
2.2 Global Influenza Virus Vaccine (H1N1), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza Virus Vaccine (H1N1) Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027)
3 Global Influenza Virus Vaccine (H1N1) Competitor Landscape by Players
3.1 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Sales
3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue
3.2.1 Key Influenza Virus Vaccine (H1N1) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza Virus Vaccine (H1N1) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza Virus Vaccine (H1N1) Revenue in 2020
3.2.6 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Virus Vaccine (H1N1) Price by Manufacturers
3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Product Types
3.4.1 Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Virus Vaccine (H1N1) Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza Virus Vaccine (H1N1) Market Size by Type (2016-2021)
4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021)
4.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021)
4.1.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
4.2.3 Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza Virus Vaccine (H1N1) Market Size by Application (2016-2021)
5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021)
5.1.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021)
5.1.3 Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
5.2 Influenza Virus Vaccine (H1N1) Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza Virus Vaccine (H1N1) Sales YoY Growth 2016-2027
6.1.2 Japan Influenza Virus Vaccine (H1N1) Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027
6.2 Japan Influenza Virus Vaccine (H1N1) Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Virus Vaccine (H1N1) Players by Sales (2016-2021)
6.2.2 Japan Top Influenza Virus Vaccine (H1N1) Players by Revenue (2016-2021)
6.3 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)
6.4 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Type (2022-2027)
6.5 Japan Influenza Virus Vaccine (H1N1) Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)
6.6 Japan Influenza Virus Vaccine (H1N1) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza Virus Vaccine (H1N1) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
7.2 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
7.2.1 North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
7.2.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
9.2 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
9.2.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
9.2.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
10.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
10.2.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Description and Business Overview
12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.1.5 CSL Recent Development
12.2 NVS(Novartis)
12.2.1 NVS(Novartis) Corporation Information
12.2.2 NVS(Novartis) Description and Business Overview
12.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Products Offered
12.2.5 NVS(Novartis) Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Description and Business Overview
12.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Medimmune
12.4.1 Medimmune Corporation Information
12.4.2 Medimmune Description and Business Overview
12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered
12.4.5 Medimmune Recent Development
12.5 GSK
12.5.1 GSK Corporation Information
12.5.2 GSK Description and Business Overview
12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered
12.5.5 GSK Recent Development
12.6 Baxter
12.6.1 Baxter Corporation Information
12.6.2 Baxter Description and Business Overview
12.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered
12.6.5 Baxter Recent Development
12.7 Beijing Kexing Bio-Vaccine
12.7.1 Beijing Kexing Bio-Vaccine Corporation Information
12.7.2 Beijing Kexing Bio-Vaccine Description and Business Overview
12.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.7.5 Beijing Kexing Bio-Vaccine Recent Development
12.8 Hualan Bio-Vaccine
12.8.1 Hualan Bio-Vaccine Corporation Information
12.8.2 Hualan Bio-Vaccine Description and Business Overview
12.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered
12.8.5 Hualan Bio-Vaccine Recent Development
12.9 Changchun Changsheng Bio-Technology
12.9.1 Changchun Changsheng Bio-Technology Corporation Information
12.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered
12.9.5 Changchun Changsheng Bio-Technology Recent Development
12.10 Beijing Tiantan Bio-Products
12.10.1 Beijing Tiantan Bio-Products Corporation Information
12.10.2 Beijing Tiantan Bio-Products Description and Business Overview
12.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Products Offered
12.10.5 Beijing Tiantan Bio-Products Recent Development
12.11 CSL
12.11.1 CSL Corporation Information
12.11.2 CSL Description and Business Overview
12.11.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CSL Influenza Virus Vaccine (H1N1) Products Offered
12.11.5 CSL Recent Development
12.12 Zhejiang Tianyuan Bio-Pharmaceutical
12.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
12.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
12.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Products Offered
12.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
12.13 Dalian Yalifeng Bio-Pharmaceutical
12.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
12.13.2 Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dalian Yalifeng Bio-Pharmaceutical Products Offered
12.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development
12.14 Sinopharm
12.14.1 Sinopharm Corporation Information
12.14.2 Sinopharm Description and Business Overview
12.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sinopharm Products Offered
12.14.5 Sinopharm Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza Virus Vaccine (H1N1) Industry Trends
13.2 Influenza Virus Vaccine (H1N1) Market Drivers
13.3 Influenza Virus Vaccine (H1N1) Market Challenges
13.4 Influenza Virus Vaccine (H1N1) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Virus Vaccine (H1N1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Vaccine
Table 3. Major Manufacturers of Nasal Spray Vaccine
Table 4. Global Influenza Virus Vaccine (H1N1) Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 5. Global Influenza Virus Vaccine (H1N1) Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Influenza Virus Vaccine (H1N1) Sales by Regions (2016-2021) & (K Doses)
Table 7. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Regions (2016-2021)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027) & (K Doses)
Table 10. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Influenza Virus Vaccine (H1N1) Sales by Manufacturers (2016-2021) (K Doses)
Table 14. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Influenza Virus Vaccine (H1N1) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Influenza Virus Vaccine (H1N1) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
Table 20. Key Manufacturers Influenza Virus Vaccine (H1N1) Price (2016-2021) (US$/Dose)
Table 21. Influenza Virus Vaccine (H1N1) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Virus Vaccine (H1N1) Product Type
Table 23. Date of International Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) (K Doses)
Table 26. Global Influenza Virus Vaccine (H1N1) Sales Share by Type (2016-2021)
Table 27. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2016-2021)
Table 29. Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose)
Table 30. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) & (K Doses)
Table 31. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose)
Table 35. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses)
Table 36. Global Influenza Virus Vaccine (H1N1) Sales Share by Application (2016-2021)
Table 37. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2016-2021)
Table 39. Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose)
Table 40. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) & (K Doses)
Table 41. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose)
Table 45. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Companies (2016-2021)
Table 46. Japan Influenza Virus Vaccine (H1N1) Sales Share by Company (2016-2021)
Table 47. Japan Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Influenza Virus Vaccine (H1N1) Revenue Share by Company (2016-2021)
Table 49. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
Table 50. Japan Influenza Virus Vaccine (H1N1) Sales Share by Type (2016-2021)
Table 51. Japan Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2016-2021)
Table 53. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2022-2027)
Table 54. Japan Influenza Virus Vaccine (H1N1) Sales Share by Type (2022-2027)
Table 55. Japan Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Influenza Virus Vaccine (H1N1) Revenue Share by Type (2022-2027)
Table 57. Japan Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2022-2027)
Table 58. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2016-2021)
Table 59. Japan Influenza Virus Vaccine (H1N1) Sales Share by Application (2016-2021)
Table 60. Japan Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2016-2021)
Table 62. Japan Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2022-2027)
Table 63. Japan Influenza Virus Vaccine (H1N1) Sales Share by Application (2022-2027)
Table 64. Japan Influenza Virus Vaccine (H1N1) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Influenza Virus Vaccine (H1N1) Revenue Share by Application (2022-2027)
Table 66. Japan Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2022-2027)
Table 67. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
Table 68. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
Table 69. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses)
Table 72. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
Table 75. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
Table 76. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
Table 77. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
Table 80. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
Table 84. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
Table 87. CSL Corporation Information
Table 88. CSL Description and Business Overview
Table 89. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 90. CSL Influenza Virus Vaccine (H1N1) Product
Table 91. CSL Recent Development
Table 92. NVS(Novartis) Corporation Information
Table 93. NVS(Novartis) Description and Business Overview
Table 94. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 95. NVS(Novartis) Product
Table 96. NVS(Novartis) Recent Development
Table 97. Sanofi Pasteur Corporation Information
Table 98. Sanofi Pasteur Description and Business Overview
Table 99. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 100. Sanofi Pasteur Product
Table 101. Sanofi Pasteur Recent Development
Table 102. Medimmune Corporation Information
Table 103. Medimmune Description and Business Overview
Table 104. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 105. Medimmune Product
Table 106. Medimmune Recent Development
Table 107. GSK Corporation Information
Table 108. GSK Description and Business Overview
Table 109. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 110. GSK Product
Table 111. GSK Recent Development
Table 112. Baxter Corporation Information
Table 113. Baxter Description and Business Overview
Table 114. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 115. Baxter Product
Table 116. Baxter Recent Development
Table 117. Beijing Kexing Bio-Vaccine Corporation Information
Table 118. Beijing Kexing Bio-Vaccine Description and Business Overview
Table 119. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 120. Beijing Kexing Bio-Vaccine Product
Table 121. Beijing Kexing Bio-Vaccine Recent Development
Table 122. Hualan Bio-Vaccine Corporation Information
Table 123. Hualan Bio-Vaccine Description and Business Overview
Table 124. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 125. Hualan Bio-Vaccine Product
Table 126. Hualan Bio-Vaccine Recent Development
Table 127. Changchun Changsheng Bio-Technology Corporation Information
Table 128. Changchun Changsheng Bio-Technology Description and Business Overview
Table 129. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 130. Changchun Changsheng Bio-Technology Product
Table 131. Changchun Changsheng Bio-Technology Recent Development
Table 132. Beijing Tiantan Bio-Products Corporation Information
Table 133. Beijing Tiantan Bio-Products Description and Business Overview
Table 134. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 135. Beijing Tiantan Bio-Products Product
Table 136. Beijing Tiantan Bio-Products Recent Development
Table 137. Jiangsu Yanshen Bio-Technology Corporation Information
Table 138. Jiangsu Yanshen Bio-Technology Description and Business Overview
Table 139. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 140. Jiangsu Yanshen Bio-Technology Product
Table 141. Jiangsu Yanshen Bio-Technology Recent Development
Table 142. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 143. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
Table 144. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 145. Zhejiang Tianyuan Bio-Pharmaceutical Product
Table 146. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
Table 147. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
Table 148. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
Table 149. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 150. Dalian Yalifeng Bio-Pharmaceutical Product
Table 151. Dalian Yalifeng Bio-Pharmaceutical Recent Development
Table 152. Sinopharm Corporation Information
Table 153. Sinopharm Description and Business Overview
Table 154. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 155. Sinopharm Product
Table 156. Sinopharm Recent Development
Table 157. Influenza Virus Vaccine (H1N1) Market Trends
Table 158. Influenza Virus Vaccine (H1N1) Market Drivers
Table 159. Influenza Virus Vaccine (H1N1) Market Challenges
Table 160. Influenza Virus Vaccine (H1N1) Market Restraints
Table 161. Influenza Virus Vaccine (H1N1) Customers List
Table 162. Influenza Virus Vaccine (H1N1) Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Virus Vaccine (H1N1) Product Picture
Figure 2. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020 & 2027
Figure 3. Intramuscular Vaccine Product Picture
Figure 4. Nasal Spray Vaccine Product Picture
Figure 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020 & 2027
Figure 6. 3 To 10 Years Old
Figure 7. 10 To 18 Years Old
Figure 8. Above 18 Years Old
Figure 9. Other
Figure 10. Influenza Virus Vaccine (H1N1) Report Years Considered
Figure 11. Global Influenza Virus Vaccine (H1N1) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Influenza Virus Vaccine (H1N1) Market Size 2016-2027 (US$ Million)
Figure 13. Global Influenza Virus Vaccine (H1N1) Sales 2016-2027 (K Doses)
Figure 14. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
Figure 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2020
Figure 17. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
Figure 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2020
Figure 19. Global Influenza Virus Vaccine (H1N1) Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2020
Figure 21. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
Figure 23. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2020
Figure 24. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
Figure 25. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type in 2020
Figure 26. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
Figure 27. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application in 2020
Figure 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
Figure 29. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application in 2020
Figure 30. Japan Influenza Virus Vaccine (H1N1) Sales Growth Rate 2016-2027 (K Doses)
Figure 31. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Influenza Virus Vaccine (H1N1) Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue in Influenza Virus Vaccine (H1N1) in 2020
Figure 34. Japan Influenza Virus Vaccine (H1N1) Revenue Share by Type (

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs